Cerebral phaeohyphomycosis caused by Fonsecaea monophora

References

• Brandt ME, Warnock DW. Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi. J Chemother 2003; 15(Suppl 2)36–47
   PubMedGoogle Scholar
• Revankar SG, Sutton DA, Rinaldi MG. Primary central nervous system phaeohyphomycosis: A review of 101 cases. Clin Infect Dis 2004; 38: 206–216
   PubMed Web of Science ®Google Scholar
• Horre R, de Hoog GS. Primary cerebral infections by melanized fungi: A review. Stud Mycol 1999; 43: 176–193
   Google Scholar
• Kantarcioglu AS, de Hoog GS. Infections of the central nervous system by melanized fungi: A review of cases presented between 1999 and 2004. Mycoses 2004; 47: 4–13
   Google Scholar
• de Hoog GS, Attili-Angekis D, Vicente VA, Gerrits Van Den Ende AHG. Molecular ecology and pathogenic potential of Fonsecaea species. Med Mycol 2004; 42: 405–416
   PubMed Web of Science ®Google Scholar
• Nobrega JP, Rosemberg S, Adami AM, et al. Fonsecaea pedrosoi cerebral phaeohyphomycosis (“chromoblastomycosis”): First human culture-proven case reported in Brazil. Rev Inst Med Trop Sao Paulo 2003; 45: 217–220
   Google Scholar
• Hiruma M, Kawada A, Ohata H, et al. Systemic phaeohyphomycosis caused by Exophiala dermatitidis. Mycoses 1993; 36: 1–7
   PubMed Web of Science ®Google Scholar
• Sutton DA, Slifkin M, Yakulis R, Rinaldi MG. U.S. case report of cerebral phaeohyphomycosis caused by Ramichloridium obovoideum (R. mackenziei): Criteria for identification, therapy, and review of other known dematiaceous neurotropic taxa. J Clin Microbiol 1998; 36: 708–715
   PubMed Web of Science ®Google Scholar
• Fukushiro R. Chromomycosis in Japan. Int J Dermatol 1983; 22: 221–229
   PubMed Web of Science ®Google Scholar
• Matos T, de Hoog GS, de Boer AG, de C I, Haase G. High prevalence of the neurotrope Exophiala dermatitidis and related oligotrophic black yeasts in sauna facilities. Mycoses 2002; 45: 373–377
   PubMed Web of Science ®Google Scholar
• de Hoog GS, Takeo K, Gottlich E, Nishimura K, Miyaji M. A human isolate of Exophiala (Wangiella) dermatitidis forming a catenate synanamorph that links the genera Exophiala and Cladophialophora. J Med Vet Mycol 1995; 33: 355–358
   PubMedGoogle Scholar
• Al-Hedaithy SS, Jamjoom ZA, Saeed ES. Cerebral phaeohyphomycosis caused by Fonsecaea pedrosoi in Saudi Arabia. APMIS Suppl 1988; 3: 94–100
   Google Scholar
• Campbell CK, Al-Hedaithy SSA. Phaeohyphomycosis of the brain caused by Ramichloridium mackenziei sp. nov. in Middle Eastern countries. J Med Vet Mycol 1993; 31: 325–332
   Google Scholar
• Lucasse C, Chardome J, Magis P. Cerebral mycosis from Cladosporium, trichoides in a native of the Belgian Congo. Ann Soc Belg Med Trop 1954; 34: 475–478
   Google Scholar
• Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000; 13: 236–301
   PubMed Web of Science ®Google Scholar
• Lirng JF, Tien RD, Osumi AK, et al. Cerebral phaeohyphomycosis complicated with brain abscess: A case report. Zhonghua Yi Xue Za Zhi (Taipei) 1995; 55: 491–495
   Google Scholar
• Groll AH, Giri N, Petraitis V, et al. Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. J Infect Dis 2000; 182: 274–282
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A, Boyle K, Sheehan DJ. In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: Review of the literature. Mycopathologia 2001; 150: 101–115
   PubMed Web of Science ®Google Scholar
• Johnson LB, Kauffman CA. Voriconazole: A new triazole antifungal agent. Clin Infect Dis 2003; 36: 630–637
   PubMed Web of Science ®Google Scholar
• Drew RH, Perfect JR. Flucytosine. Antimicrobial Therapy and Vaccines1st edn, VL Yu, TC Merigan, Jr, SL Barriere. Williams & Wilkins, Baltimore 1999; 1170–1184
   Google Scholar
• Sharkey PK, Graybill JR, Rinaldi MG, et al. Itraconazole treatment of phaeohyphomycosis. J Am Acad Dermatol 1990; 23: 577–586
   PubMed Web of Science ®Google Scholar
• Groll AH, Walsh TJ. Azoles: Triazoles. Antimicrobial Therapy and Vaccines1st edn, VL Yu, TC Merigan, Jr, SL Barriere. Williams & Wilkins, Baltimore 1999; 1158–1170
   Google Scholar
• Dixon DM, Walsh TJ, Merz WG, McGinnis MR. Infections due to Xylohypha bantiana (Cladosporium trichoides). Rev Infect Dis 1989; 11: 515–525
   PubMedGoogle Scholar